Triheptanoin in patients with long-chain fatty acid oxidation disorders: clinical experience in Italy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Triheptanoin in patients with long-chain fatty acid oxidation disorders: clinical experience in Italy ; volume:50 ; number:1 ; day:7 ; month:10 ; year:2024 ; pages:1-9 ; date:12.2024
The Italian journal of pediatrics ; 50, Heft 1 (7.10.2024), 1-9, 12.2024
- Creator
-
Porta, Francesco
Maiorana, Arianna
Gragnaniello, Vincenza
Procopio, Elena
Gasperini, Serena
Taurisano, Roberta
Spada, Marco
Dionisi-Vici, Carlo
Burlina, Alberto
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13052-024-01782-y
- URN
-
urn:nbn:de:101:1-2412242110130.094249802325
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:39 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Porta, Francesco
- Maiorana, Arianna
- Gragnaniello, Vincenza
- Procopio, Elena
- Gasperini, Serena
- Taurisano, Roberta
- Spada, Marco
- Dionisi-Vici, Carlo
- Burlina, Alberto
- SpringerLink (Online service)
Other Objects (12)
Long-chain fatty acid oxidation disorders
Long-chain fatty acid oxidation disorders : understand, identify and support
Neurological outcome in long‐chain hydroxy fatty acid oxidation disorders
Different lipid signature in fibroblasts of long-chain fatty acid oxidation disorders
Carnitine homeostasis and dietary modification in long-chain fatty acid oxidation disorders
Disorders of mitochondrial long-chain fatty acid oxidation and the carnitine shuttle
Synthesis and optimization of long-chain fatty acids via the oxidation of long-chain fatty alcohols
Psychosocial issues and coping strategies in families affected by long‐chain fatty acid oxidation disorders
Triheptanoin in the management of long-chain fatty acid oxidation disorders: a profile of its use
Estimating the Prevalence of Rare Diseases: Long-Chain Fatty Acid Oxidation Disorders as an Illustrative Example
Long-term experience with triheptanoin in 12 Austrian patients with long-chain fatty acid oxidation disorders
Correction to: Triheptanoin in the management of long‑chain fatty acid oxidation disorders: a profile of its use
Long-chain fatty acid oxidation disorders
Long-chain fatty acid oxidation disorders : understand, identify and support
Neurological outcome in long‐chain hydroxy fatty acid oxidation disorders
Different lipid signature in fibroblasts of long-chain fatty acid oxidation disorders
Carnitine homeostasis and dietary modification in long-chain fatty acid oxidation disorders
Disorders of mitochondrial long-chain fatty acid oxidation and the carnitine shuttle
Synthesis and optimization of long-chain fatty acids via the oxidation of long-chain fatty alcohols
Psychosocial issues and coping strategies in families affected by long‐chain fatty acid oxidation disorders
Triheptanoin in the management of long-chain fatty acid oxidation disorders: a profile of its use
Estimating the Prevalence of Rare Diseases: Long-Chain Fatty Acid Oxidation Disorders as an Illustrative Example
Long-term experience with triheptanoin in 12 Austrian patients with long-chain fatty acid oxidation disorders
Correction to: Triheptanoin in the management of long‑chain fatty acid oxidation disorders: a profile of its use
Long-chain fatty acid oxidation disorders
Long-chain fatty acid oxidation disorders : understand, identify and support
Neurological outcome in long‐chain hydroxy fatty acid oxidation disorders
Different lipid signature in fibroblasts of long-chain fatty acid oxidation disorders
Carnitine homeostasis and dietary modification in long-chain fatty acid oxidation disorders
Disorders of mitochondrial long-chain fatty acid oxidation and the carnitine shuttle
Synthesis and optimization of long-chain fatty acids via the oxidation of long-chain fatty alcohols
Psychosocial issues and coping strategies in families affected by long‐chain fatty acid oxidation disorders
Triheptanoin in the management of long-chain fatty acid oxidation disorders: a profile of its use
Estimating the Prevalence of Rare Diseases: Long-Chain Fatty Acid Oxidation Disorders as an Illustrative Example
Long-term experience with triheptanoin in 12 Austrian patients with long-chain fatty acid oxidation disorders